Activation of Androgen Receptor, Lipogenesis, and Oxidative Stress Converged by SREBP-1 Is Responsible for Regulating Growth and Progression of Prostate Cancer Cells

被引:185
|
作者
Huang, Wen-Chin [1 ]
Li, Xiangyan [1 ]
Liu, Jian [2 ]
Lin, Jentai [3 ]
Chung, Leland W. K. [1 ]
机构
[1] Cedars Sinai Med Ctr, Urooncol Res Program, Dept Med, Los Angeles, CA 90048 USA
[2] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA USA
[3] Natl Cheng Kung Univ, Grad Inst Clin Med, Tainan 70101, Taiwan
关键词
ELEMENT-BINDING PROTEINS; FATTY-ACID SYNTHASE; FARNESYL DIPHOSPHATE SYNTHASE; BOUND TRANSCRIPTION FACTOR; HYDROGEN-PEROXIDE; METABOLIC ONCOGENE; STEROL REGULATION; NUCLEAR-PROTEIN; KINASE-A; IN-VITRO;
D O I
10.1158/1541-7786.MCR-11-0206
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We previously reported that sterol regulatory element-binding protein-1 (SREBP-1) is involved in the transcriptional regulation of androgen receptor (AR) and formation of fatty acid through altered expression of fatty acid synthase (FASN). In this article, we provide a new finding that SREBP-1 induced oxidative stress in prostate cancer cells through increased production of reactive oxygen species (ROS) and expression of NADPH oxidase 5 (Nox5). We have shown that (i) expression of SREBP-1 protein is positively associated with the clinical Gleason grades in human prostate cancer; (ii) genetic overexpression or knockdown of SREBP-1 in prostate cancer cells resulted in corresponding increased or decreased AR, FASN and Nox5 expression, fatty acid and lipid droplet accumulation, and ROS generation; and (iii) SREBP-1 induces and promotes the growth, migration, invasion, and castration-resistant progression of prostate cancer cells in vitro and in vivo. Our data show a novel molecular mechanism by which SREBP-1 promotes prostate cancer growth and progression through alterations in the concerted intracellular metabolic and signaling networks involving AR, lipogenesis, and ROS in prostate cancer cells. Mol Cancer Res; 10(1); 133-42. (C) 2011 AACR.
引用
收藏
页码:133 / 142
页数:10
相关论文
共 50 条
  • [21] Androgen Receptor Regulation of Local Growth Hormone in Prostate Cancer Cells
    Recouvreux, M. Victoria
    Wu, J. Boyang
    Gao, Allen C.
    Zonis, Svetlana
    Chesnokova, Vera
    Bhowmick, Neil
    Chung, Leland W.
    Melmed, Shlomo
    ENDOCRINOLOGY, 2017, 158 (07) : 2255 - 2268
  • [22] Androgen Receptor Expression in Prostate Cancer Cells Is Suppressed by Activation of Epidermal Growth Factor Receptor and ErbB2
    Cai, Changmeng
    Portnoy, David C.
    Wang, Hongyun
    Jiang, Xinnong
    Chen, Shaoyong
    Balk, Steven P.
    CANCER RESEARCH, 2009, 69 (12) : 5202 - 5209
  • [23] Activation of β-Catenin Signaling in Androgen Receptor-Negative Prostate Cancer Cells
    Wan, Xinhai
    Liu, Jie
    Lu, Jing-Fang
    Tzelepi, Vassiliki
    Yang, Jun
    Starbuck, Michael W.
    Diao, Lixia
    Wang, Jing
    Efstathiou, Eleni
    Vazquez, Elba S.
    Troncoso, Patricia
    Maity, Sankar N.
    Navone, Nora M.
    CLINICAL CANCER RESEARCH, 2012, 18 (03) : 726 - 736
  • [24] Autophagy activation and SREBP-1 induction contribute to fatty acid metabolic reprogramming by leptin in breast cancer cells
    Duc-Vinh Pham
    Pun, Nirmala Tilija
    Park, Pil-Hoon
    MOLECULAR ONCOLOGY, 2021, 15 (02) : 657 - 678
  • [25] Endostatin inhibits androgen-independent prostate cancer growth by suppressing nuclear receptor-mediated oxidative stress
    Lee, Joo Hyoung
    Kang, Minsung
    Naik, Gurudatta
    Mobley, James A.
    Sonpavde, Guru
    Garvey, W. Timothy
    Darley-Usmar, Victor M.
    Ponnazhagan, Selvarangan
    CANCER RESEARCH, 2017, 77
  • [26] Endostatin inhibits androgen-independent prostate cancer growth by suppressing nuclear receptor-mediated oxidative stress
    Lee, Joo Hyoung
    Kang, Minsung
    Wang, Hong
    Naik, Gurudatta
    Mobley, James A.
    Sonpavde, Guru
    Garvey, W. Timothy
    Darley-Usmar, Victor M.
    Ponnazhagan, Selvarangan
    FASEB JOURNAL, 2017, 31 (04): : 1608 - 1619
  • [27] The role of DAB2IP in androgen receptor activation during prostate cancer progression
    Wu, K.
    Liu, J.
    Tseng, S-F
    Gore, C.
    Ning, Z.
    Sharifi, N.
    Fazli, L.
    Gleave, M.
    Kapur, P.
    Xiao, G.
    Sun, X.
    Oz, O. K.
    Min, W.
    Alexandrakis, G.
    Yang, C-R
    Hsieh, C-L
    Wu, H-C
    He, D.
    Xie, D.
    Hsieh, J-T
    ONCOGENE, 2014, 33 (15) : 1954 - 1963
  • [28] The role of DAB2IP in androgen receptor activation during prostate cancer progression
    K Wu
    J Liu
    S-F Tseng
    C Gore
    Z Ning
    N Sharifi
    L Fazli
    M Gleave
    P Kapur
    G Xiao
    X Sun
    O K Oz
    W Min
    G Alexandrakis
    C-R Yang
    C-L Hsieh
    H-C Wu
    D He
    D Xie
    J-T Hsieh
    Oncogene, 2014, 33 : 1954 - 1963
  • [29] Epidermal growth factor receptor (ErbB1) expression in prostate cancer progression: Correlation with androgen independence
    Shah, Rajal B.
    Ghosh, Debashis
    Elder, James T.
    PROSTATE, 2006, 66 (13): : 1437 - 1444
  • [30] ACTIVATION OF ABERRANT ANDROGEN RECEPTOR SIGNALING IN CARCINOMA ASSOCIATED FIBROBLASTS INDUCES PROSTATE CANCER PROGRESSION
    Franco, Omar E.
    Javier, Rodrigo
    Crawford, Susan E.
    Ayala, Gustavo E.
    Hayward, Simon W.
    JOURNAL OF UROLOGY, 2016, 195 (04): : E817 - E818